Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space. With international facilities and a global distribution network, Zymo Research enables researchers in academia and the biomedical field to make cutting-edge discoveries all over the world. While the company provides some of the most technologically advanced products in the industry, everything is driven by the fundamental belief that “the beauty of science is to make things simple.”
Upcera Dental America
Upcera is the global leader in dental zirconia. We provide a full range of digital dental solutions for laboratories and clinicians. Our product lines high-quality zirconia discs, CAD/CAM Milling machines, dental furnaces, and chairside solutions.
Tecan
At Tecan we are driven to improve people’s lives and health. We do this by empowering our customers to scale healthcare innovation globally from life science to the clinic. We collaborate with our customers in healthcare and the life sciences, from early-stage innovation through project implementation and beyond. We deliver the products, services and solutions that make lab processes and medical procedures precise, reproducible and compliant. This leads to scalable outcomes that are further reaching and ever more valuable to humankind. | Tecan is a global leader in life sciences and diagnostics, offering cutting-edge solutions that span genomics, automation, and personalized medical research. With a strong focus on workflow integration, Tecan delivers modular platforms and reagents that support every step of the genomics pipeline—from nucleic acid purification and quantification to PCR setup and next-generation sequencing (NGS) library preparation. Tecan’s automation systems, including MagicPrep® NGS and DreamPrep® NGS, provide walkaway solutions that simplify complex protocols, reduce errors, and increase throughput. These platforms enable broad and targeted genomic applications, which streamlines sequencing workflows for infectious disease and oncology research. Tecan’s commitment to standardization, scalability, and sustainability makes it a trusted partner for academic, clinical, and industrial research labs worldwide. By integrating automation with advanced reagents and collaborative development, Tecan is helping transform research into real-world medical impact. | Tecan supports the full product journey for complex MedTech, IVD, and life science systems, from critical components through development and manufacturing. Our teams specialize in high-mix, high-complexity programs that require disciplined processes and dependable execution. Through our contract manufacturing capabilities, we combine structured design transfer and vPoke® computer-directed assembly to deliver consistent results from pilot builds through scale. In parallel, our Cavro® components team provides precision liquid handling solutions that form the foundation of many complex instruments. With manufacturing in the US and Malaysia, FDA-approved facilities, and decades of experience across regulated industries, Tecan helps teams move forward with confidence, predictability, and long-term support. | Tecan is uniquely qualified to solve your most difficult technology and product-design problems. Our approach blends fundamental science and engineering to deliver limitless technology development. We take your ideas from concept to advanced functional prototype quickly, accurately and cost-effectively with our fixed price engagement model.
Tasso, Inc.
Tasso is a healthcare technology company transforming traditional blood collection with a patient-centric, virtually painless approach. Its devices enable simple, remote blood sampling for users and healthcare providers. Headquartered in Seattle, Washington, Tasso is privately held and supported through grants, investments, and partnerships with leading research and industry organizations. Learn more at www.tassoinc.com.
Takara Bio USA, Inc.
For over 50 years, Takara Bio has been committed to helping scientists break new ground with our innovative technologies. Our extensive portfolio of reagents, instruments, and services support advancements in the life sciences, including frontline diagnostics and clinical applications. e take pride in our market-leading product portfolio, which support a wide range of applications including CAR-T therapy, immune profiling, genetic screening, cell and gene therapy, infectious disease research, vaccine development, drug discovery, antibiotic-resistance screening, and cancer research to name a few.
SynOligo Biotechnologies
Headquartered in Morrisville, NC, USA, Synoligo Biotechnologies is a Contract Research and Development Organization (CRDO) specialized in manufacturing complex and highly modified oligonucleotide for academic, biotech start-up and large pharmaceutical communities. Synoligo is a leading oligonucleotide manufacturing company providing high quality, cost-effective custom oligonucleotides at varying scales for research, diagnostic, and therapeutic applications.
STRATEC SE
STRATEC (www.stratec.com) is one of the world’s leading OEM providers of automated solutions in the fields of in-vitro diagnostics and life sciences. The Group’s product range includes fully automated analyzer systems, software and smart polymer consumables. STRATEC covers the entire value chain – from development and manufacturing through to quality assurance. Partners worldwide rely on STRATEC’s expertise in providing market-leading diagnostic systems as well as high precision molding for microfluidic products. The company’s solutions are used in the technological fields of immunoassays, molecular diagnostics, immunohematology and hematology, which means they are used in blood banks, laboratories, hospitals and doctors’ offices worldwide. The STRATEC Group, headquartered in Birkenfeld, Germany, operates globally and has offices as well as manufacturing sites in the US, Europe and Asia. The group also includes the companies Diatron and Natech Plastics.
seqWell, Inc.
seqWell creates scalable genomics technologies that simplify NGS library preparation workflows and helps scientists to unlock transformative discoveries with sequencing. seqWell technology is focused on a novel, next-generation transposase, TnX™, to drive the scalability and high-performance needs of tagmentation and advance NGS. seqWell offers a range of library prep products, fragmentation workflows and sequencing services that allow customers to quickly and easily scale their short- and long-read sequencing initiatives. Learn more at www.seqwell.com or follow us on Linkedin.
Seer
At Seer, we develop innovative solutions that act as a gateway to the proteome. Our goal is to empower the scientific community with tools to achieve exceptional scientific outcomes. We do this by removing the technological barriers that stand between breakthrough ideas and the information that can make them a reality. Seer’s Proteograph Product Suite provides the only proteomics workflow that enables deep, unbiased proteomic content at scale, at the peptide level. With the Proteograph Product Suite, we are making the proteome even more accessible, not just to the proteomics community, but also to genomics researchers, who are eager to deeply characterize genomic variants with functional proteomic information, deepening their biological insights. Adding deep, unbiased, peptide-level proteomics data to research studies can provide unrivaled insight into biology, disease progression, and targets for precision diagnostics and therapeutics. We look forward to meeting you at AACR. | Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others do not. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit www.seer.bio.